PlainRecalls
FDA Drug Low Class III Terminated

Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA

Reported: December 25, 2019 Initiated: December 10, 2019 #D-0629-2020

Product Description

Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA

Reason for Recall

Failed Dissolution Specifications: High out of specification result observed at stability studies.

Details

Units Affected
3,726 bottles
Distribution
Nationwide in the USA
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 3,726 bottles.
Why was this product recalled?
Failed Dissolution Specifications: High out of specification result observed at stability studies.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 25, 2019. Severity: Low. Recall number: D-0629-2020.